Your browser doesn't support javascript.
loading
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Ceriani, Luca; Milan, Lisa; Cascione, Luciano; Gritti, Giuseppe; Dalmasso, Federico; Esposito, Fabiana; Pirosa, Maria Cristina; Schär, Sämi; Bruno, Andrea; Dirnhofer, Stephan; Giovanella, Luca; Hayoz, Stefanie; Mamot, Christoph; Rambaldi, Alessandro; Chauvie, Stephane; Zucca, Emanuele.
Affiliation
  • Ceriani L; Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Milan L; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Cascione L; Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Gritti G; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Dalmasso F; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Esposito F; Hematology Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Pirosa MC; Medical Physics Unit, Santa Croce e Carlo Hospital, Cuneo, Italy.
  • Schär S; Medical Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Bruno A; Medical Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Dirnhofer S; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • Giovanella L; Department of Nuclear Medicine, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Hayoz S; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Switzerland.
  • Mamot C; Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Rambaldi A; Department of Nuclear Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Chauvie S; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • Zucca E; Division of Oncology, Cantonal Hospital Aarau, Aarau, Switzerland.
Hematol Oncol ; 40(1): 11-21, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34714558
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron Emission Tomography Computed Tomography Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron Emission Tomography Computed Tomography Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2022 Document type: Article Affiliation country: